Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil H Shear

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 3, 2002
Principles of influenceNeil H Shear
Drug Safety|February 4, 2006
Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?Neil H Shear
ACP Journal Club|January 4, 2008
Review: oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosisNeil H Shear
Archives of Dermatology|September 22, 2010
Skin conditions that bring patients to emergency departmentsAkerke Baibergenova, Neil H Shear
Paediatric Drugs|July 12, 2013
Cutaneous drug reactions in children: an updateKara Heelan, Neil H Shear
Journal of the American Academy of Dermatology|March 29, 2003
Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?Rochelle Mandelcorn, Neil H Shear
Journal of Cutaneous Medicine and Surgery|September 4, 2019
New Perspectives on Topical Calcineurin Inhibitors: Role in Dermatology Today and Into the FutureAfsaneh Alavi, Neil H Shear
Dermatologic Therapy|October 23, 2009
Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrumSandra Knowles, Neil H Shear
American Journal of Clinical Dermatology|June 9, 2012
Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?Raed Alhusayen, Neil H Shear
Expert Opinion on Drug Safety|March 18, 2020
An update on the safety of apremilast for the treatment of plaque psoriasisEran Shavit, Neil H Shear
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 3, 2002
Principles of influenceNeil H Shear
Drug Safety|February 4, 2006
Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?Neil H Shear
ACP Journal Club|January 4, 2008
Review: oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosisNeil H Shear
Archives of Dermatology|September 22, 2010
Skin conditions that bring patients to emergency departmentsAkerke Baibergenova, Neil H Shear
Paediatric Drugs|July 12, 2013
Cutaneous drug reactions in children: an updateKara Heelan, Neil H Shear
Journal of the American Academy of Dermatology|March 29, 2003
Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?Rochelle Mandelcorn, Neil H Shear
Journal of Cutaneous Medicine and Surgery|September 4, 2019
New Perspectives on Topical Calcineurin Inhibitors: Role in Dermatology Today and Into the FutureAfsaneh Alavi, Neil H Shear
Dermatologic Therapy|October 23, 2009
Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrumSandra Knowles, Neil H Shear
American Journal of Clinical Dermatology|June 9, 2012
Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?Raed Alhusayen, Neil H Shear
Expert Opinion on Drug Safety|March 18, 2020
An update on the safety of apremilast for the treatment of plaque psoriasisEran Shavit, Neil H Shear
Pageof 20